CARE Ratings Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹112Cr
- +16.7% YoY
- −17.6% QoQ
- Net profit
- ₹37Cr
- +32.1% YoY
- −35.1% QoQ
- Margin
- 36%
- +4 pp YoY
- −14 pp QoQ
Guidance rank: #20 of 27 in Capital Markets
See the sector's top 10 — free with your mobile number.
Based on CARE Ratings Ltd's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q3 FY26 Standalone Revenue from Operations: Rs. 90.24 Crs, up 15% YoY (Page 12, 2). Q3 FY26 Standalone:.
From CARE Ratings Ltd's Q3 FY26 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Q3 FY26 Standalone Revenue from Operations: Rs. 90.24 Crs, up 15% YoY (Page 12, 2)
- Q3 FY26 Consolidated Revenue from Operations: Rs. 112.12 Crs, up 16% YoY (Page 12, 2)
- Ratings Segment Revenue (9M FY26): Rs. 305.69 Crs, 17% growth YoY (Page 14, 10; Page 2, 2)
2 more points from CARE Ratings Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
Q3 FY26 Standalone:
Locked: what CARE Ratings Ltd said on margins
Also locked on this page: capex, fundraising, order book
Free account, 30 seconds. No card needed.
Capital Expenditure Plans
See what CARE Ratings Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Capital Markets
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
Corporate bond and commercial paper issuances are discussed in terms of market activity (Page 8), showing:
Locked: what CARE Ratings Ltd said on fundraising
Also locked on this page: margins, capex, order book
Free account, 30 seconds. No card needed.
Order Book & Pipeline
See what CARE Ratings Ltd said on order book & pipeline — free account, 30 seconds.
CARE Ratings Ltd — Quarterly revenue & net profit
CARE Ratings Ltd Q3 FY26 results — key figures
| ₹ Cr | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 112 | 96 | +16.7% | 136 | -17.6% |
| Operating profit (EBITDA) | 40 | 30 | +33.3% | 68 | -41.2% |
| Operating margin | 36% | 32% | +4 pp | 50% | -14 pp |
| Profit before tax | 49 | 39 | +25.6% | 77 | -36.4% |
| Net profit (PAT) | 37 | 28 | +32.1% | 57 | -35.1% |
| EPS (₹) | 11.96 | 9.29 | +28.7% | 18.89 | -36.7% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹164 Cr, net profit ₹72 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What CARE Ratings's management said in earlier quarters
Others in Capital Markets this season
- Emkay Global Financial Services (Q3 FY26)
Q3 FY26 Income from Operations: INR 871 Mn, up 13% YoY from INR 773 Mn in Q3 FY25 (Page 33) . Key investor presentation takeaways from Emkay Global Financial Se
- Systematix Corporate Services (Q3 FY26)
Revenue from operations (consolidated) for Q3 FY26: ₹33.60 crore . Key investor presentation takeaways from Systematix Corporate Services Ltd's Q3 FY26 investor
- ICRA (Q3 FY26)
Q3 FY2026 revenue: ₹163.6 crore, up from ₹120.9 crore in Q3 FY2025 — a 35.3% year-on-year (YoY) increase (Page 7). Key concall takeaways from ICRA Ltd's Q3…
- UTI AMC (Q3 FY26)
Core income (Sale of Services): ₹322 crore, up 5% YoY . Key concall takeaways from UTI Asset Management Company Ltd's Q3 FY26 earnings call — and how it ranks…
Potential multibaggers · Q2 FY27
Potential multibaggers in Capital Markets
on management's own guidance
- Motilal Oswal Financial ServicesGood growth2
- BSEGood growth1
- Anand Rathi WealthGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
CARE Ratings Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were CARE Ratings Ltd Q3 FY26 results?
Q3 FY26 Standalone Revenue from Operations: Rs. 90.24 Crs, up 15% YoY (Page 12, 2). Q3 FY26 Standalone:.
What is CARE Ratings Ltd share price analysis?
CARE Ratings Ltd currently shows a neutral. The stock trades at a P/E of 28.3 with a market cap of ₹5,026 Cr. Investors should review the full earnings analysis for detailed insights.
Keep CARE Ratings Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.